OCUGEN, INC. Common Stock, Capital Shares Reserved for Future Issuance
OCUGEN, INC. (OCGN) had Common Stock, Capital Shares Reserved for Future Issuance of 36.48 million shares as of 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2019-03-22
- 2018-12-31: Common Stock, Capital Shares Reserved for Future Issuance 36.48M shares.
- 2017-12-31: Common Stock, Capital Shares Reserved for Future Issuance 15.79M shares.
- 2016-12-31: Common Stock, Capital Shares Reserved for Future Issuance 15.21M shares.
- 2015-12-31: Common Stock, Capital Shares Reserved for Future Issuance 1.39M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 1.39M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2018-12-31 | 36.48M shares 10-K · filed 2019-03-22 | |
| 2017-12-31 | 15.79M shares 10-K · filed 2019-03-22 | |
| 2016-12-31 | 15.21M shares 10-K · filed 2018-03-15 | |
| 2015-12-31 | 1.39M shares 10-K · filed 2017-03-16 | 1.39M shares 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |